Jason Fredette | executive |
Martin Huber | executive |
Brian DeSchuytner | executive |
Tara Bancroft | analyst |
Kaveri Pohlman | analyst |
Dylan Drakes | analyst |
Lut Ming Cheng | analyst |
Michael Schmidt | analyst |
Asthika Goonewardene | analyst |
Ashiq Mubarack | analyst |
Colleen Hanley | analyst |
Good morning, and welcome to Mersana Therapeutics' First Quarter 2024 Conference Call and Webcast. [Operator Instructions] I would like now to turn the call over to Jason Fredette, Senior Vice President, Investor Relations and Corporate Communications. Please note, this call is being recorded.
Thank you, operator, and good morning, everyone.
Before we begin, please note that this call will contain forward-looking statements within the meaning of federal securities laws.